People with depression have fewer cannabinoid receptor type 1 (CB1) in astrocytes. Boosting CB1 could be a future treatment for anxiety & depression #neuroscience #mentalhealth #medindia ...

"When faced with chronic stress, some people develop anxiety and depressive symptoms, while others show great resilience. How ...

The drug, known as VIP36, targets the body’s cannabinoid receptor type 1 (CB1). It was found to be effective in three ...

“The protein, called cannabinoid receptor type 1 (CB1), is part of the blood-brain barrier, the dynamic structure that protects the brain by regulating the passage of molecules between the blood ...

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? A protein that acts as a cannabinoid receptor and is present in the structure ...

A study published in Nature Neuroscience suggests that the cannabinoid receptor type 1 (CB1) could play a role in regulating stress responses by maintaining vascular integrity in the brain. The ...

Scientists have discovered that a specific type of brain cell, called an astrocyte, may be a key player in how cannabis influences the developing brain. Their new research in mice, published in ...

In this form of retrograde signaling, the molecules are released from the post-synaptic neuron and bind to cannabinoid (CB1) receptors on the pre-synaptic neuronal axon. Though the activity of the ...

“The protein, called cannabinoid receptor type 1 (CB1), is part of the blood-brain barrier, the dynamic structure that protects the brain by regulating the passage of molecules between the blood ...